169 related articles for article (PubMed ID: 22323035)
1. [A case of severe hypokalemia caused by a Chinese herbal remedy (Yokukansan) in an 81-year-old woman with dementia].
Nishiyama N; Takeshita M; Tanaka K; Miyao M; Mizuno Y
Nihon Ronen Igakkai Zasshi; 2011; 48(5):553-7. PubMed ID: 22323035
[TBL] [Abstract][Full Text] [Related]
2. Severe metabolic alkalosis, hypokalemia, and respiratory acidosis induced by the Chinese herbal medicine yokukansan in an elderly patient with muscle weakness and drowsiness.
Yamada S; Tokumoto M; Kansui Y; Wakisaka Y; Uchizono Y; Tsuruya K; Ooboshi H
CEN Case Rep; 2013 May; 2(1):23-27. PubMed ID: 28509214
[TBL] [Abstract][Full Text] [Related]
3. Geriatric Patients Are at a High Risk of Hypokalemia Associated with Yokukansan Preparation: A Retrospective Cohort Study.
Hirai T; Yamaga R; Kei M; Hosohata K; Itoh T
Biol Pharm Bull; 2020; 43(11):1742-1748. PubMed ID: 33132320
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database.
Ishida T; Kawada K; Morisawa S; Jobu K; Morita Y; Miyamura M
Biol Pharm Bull; 2020; 43(10):1570-1576. PubMed ID: 32999167
[TBL] [Abstract][Full Text] [Related]
5. Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study.
Shimada S; Arai T; Tamaoka A; Homma M
BMJ Open; 2017 Jun; 7(6):e014218. PubMed ID: 28619768
[TBL] [Abstract][Full Text] [Related]
6. Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Kinoshita H; Okabayashi M; Kaneko M; Yasuda M; Abe K; Machida A; Ohkubo T; Kamata T; Yakushiji F
J Altern Complement Med; 2009 Apr; 15(4):439-43. PubMed ID: 19388868
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of five elderly patients with severe hypokalemia induced by glycyrrhizin derivatives].
Yamamoto T; Hatanaka M; Matsuda J; Kadoya H; Takahashi A; Namba T; Takeji M; Yamauchi A
Nihon Jinzo Gakkai Shi; 2010; 52(1):80-5. PubMed ID: 20166546
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
[TBL] [Abstract][Full Text] [Related]
9. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
[TBL] [Abstract][Full Text] [Related]
10. [Case of rhabdomyolysis induced by the approved daily dose of a traditional Chinese medicine].
Toyohara T; Tanemoto M; Uruno A; Abe M; Abe T; Ito S
Nihon Jinzo Gakkai Shi; 2008; 50(2):135-9. PubMed ID: 18421970
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
[TBL] [Abstract][Full Text] [Related]
12. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
[TBL] [Abstract][Full Text] [Related]
13. A Case of Pseudohyperaldosteronism Induced by Yokukansan and Shakuyakukanzoto That Resulted in Severe Hypokalemia.
Arai M; Isono H; Isono M; Ihara K; Kondo K
Cureus; 2023 Apr; 15(4):e38267. PubMed ID: 37261160
[TBL] [Abstract][Full Text] [Related]
14. [Case of severe hypokalemia during emergency surgery caused by long-term administration of Shakuyaku-kanzo-to].
Yasuda T; Hirasaki Y; Oguchi M; Tajima K
Masui; 2011 Feb; 60(2):244-6. PubMed ID: 21384669
[TBL] [Abstract][Full Text] [Related]
15. [Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels].
Homma M; Ishihara M; Qian W; Kohda Y
Yakugaku Zasshi; 2006 Oct; 126(10):973-8. PubMed ID: 17016026
[TBL] [Abstract][Full Text] [Related]
16. Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitor.
Iida R; Otsuka Y; Matsumoto K; Kuriyama S; Hosoya T
Clin Exp Nephrol; 2006 Jun; 10(2):131-5. PubMed ID: 16791400
[TBL] [Abstract][Full Text] [Related]
17. Acute Kidney Injury Impacts on Hypokalemia Associated with Yokukansan Preparation: A Retrospective Observational Study.
Hirai T; Yamaga R; Kei M; Hosohata K; Itoh T
Biol Pharm Bull; 2021; 44(1):118-124. PubMed ID: 33390538
[TBL] [Abstract][Full Text] [Related]
18. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
[TBL] [Abstract][Full Text] [Related]
19. [Licorice of 'shakuyaku kanzou tou' induced pseudoaldosteronism].
Kanda H; Sakurai M; Arima K
Hinyokika Kiyo; 2004 Mar; 50(3):215-7. PubMed ID: 15148778
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms.
Kimura T; Hayashida H; Furukawa H; Takamatsu J
Psychiatry Clin Neurosci; 2010 Apr; 64(2):207-10. PubMed ID: 20447015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
